BR9815384A - Composições de unguento em aerossol e método de fabricação - Google Patents

Composições de unguento em aerossol e método de fabricação

Info

Publication number
BR9815384A
BR9815384A BR9815384-6A BR9815384A BR9815384A BR 9815384 A BR9815384 A BR 9815384A BR 9815384 A BR9815384 A BR 9815384A BR 9815384 A BR9815384 A BR 9815384A
Authority
BR
Brazil
Prior art keywords
ointment
aerosol
relief
pain
percent
Prior art date
Application number
BR9815384-6A
Other languages
English (en)
Inventor
Lloyd I Osipow
Dorothea C Marra
George J Spitzer
Original Assignee
Oms Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oms Holdings Llc filed Critical Oms Holdings Llc
Publication of BR9815384A publication Critical patent/BR9815384A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

''COMPOSIçõES DE UNGuENTO EM AEROSSOL E MéTODO DE FABRICAçãO'' São proporcionadas composições de ung³ento em aerossol que, quando um depósito é expelido a partir de um recipiente aerossol por sobre um tecido machucado, é aplicado ao referido tecido um ung³ento frio através do que se exerce um efeito refrescante que alivia a dor e um efeito terapêutico medicinal sobre os referidos tecidos. Exemplos de ung³entos típicos da invenção são aqueles para o alívio temporário das hemorróidas, tratamento de queimaduras provocadas pelo sol e alívio da dor artrítica. Um método para a fabricação das composições de ung³ento em aerossol capazes de expelir a partir de recipientes aerossol ung³entos que exerçam sobre os tecidos danificados tanto um efeito refrescante que alivia a dor além de um efeito terapêutico medicinal. As composições aerossol que melhoram a ação terapêutica de um ung³ento através da produção de um instantâneo efeito refrescante prolongado proporciona rápido alívio para a dor e coceira bem como uma tendência à retração de tecidos inflamados e intumescidos antecipadamente à ação mais lenta de qualquer medicamento presente no ung³ento, onde a composição aerossol consiste de a partir de cerca de 10 até cerca de 60 por cento em peso de um componente ung³ento e a partir de cerca de 40 até cerca de 90 porcento em peso de propelente liq³efeito que é um propelente predominantemente não polar, e onde a soma do componente ung³ento e propelente e igual a 100 por cento em peso da composição.
BR9815384-6A 1997-10-02 1998-09-30 Composições de unguento em aerossol e método de fabricação BR9815384A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94753097A 1997-10-02 1997-10-02
US7506798A 1998-05-08 1998-05-08
PCT/US1998/020335 WO1999017739A1 (en) 1997-10-02 1998-09-30 Aerosol ointment compositions and method of manufacture

Publications (1)

Publication Number Publication Date
BR9815384A true BR9815384A (pt) 2000-10-31

Family

ID=26756400

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9815384-6A BR9815384A (pt) 1997-10-02 1998-09-30 Composições de unguento em aerossol e método de fabricação

Country Status (7)

Country Link
EP (1) EP1019024B1 (pt)
AT (1) ATE257372T1 (pt)
AU (1) AU9588598A (pt)
BR (1) BR9815384A (pt)
CA (1) CA2306484A1 (pt)
DE (1) DE69821010T2 (pt)
WO (1) WO1999017739A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214318B1 (en) * 1997-10-02 2001-04-10 Oms Holdings Llc Aerosol ointment compositions for topical use
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
NZ563560A (en) 2005-06-01 2009-11-27 Stiefel Res Australia Pty Ltd Vitamin formulation for treating a dermatological skin disorder
WO2020223093A1 (en) 2019-04-30 2020-11-05 Bayer Healthcare Llc Topical analgesic gel compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1123868A (en) * 1965-09-08 1968-08-14 Philips Roxane Compositions for treating anal and perianal disorders
US3947566A (en) * 1970-08-03 1976-03-30 Phoenix Research Inc. Effervescent medicaments
ZA77943B (en) * 1976-03-19 1977-12-28 Upjohn Co Topical steroid clindamycin preparations
GB1539450A (en) * 1976-06-08 1979-01-31 Wyeth John & Brother Ltd Thiazole derivatives
DE3810730A1 (de) * 1988-03-30 1989-10-12 Desitin Arzneimittel Gmbh Spruehbare salbenzusammensetzung
WO1992011839A1 (en) * 1991-01-08 1992-07-23 Leonard Mackles Anhydrous aerosol
CA2110176A1 (en) * 1992-03-28 1993-10-14 Akira Yanagawa Topical preparation for healing wounds of the skin
US5618515A (en) * 1992-08-19 1997-04-08 Blistex Inc. Aerosol spray composition for the treatment of dermal burns by cooling and anesthetizing the wound and valved container for dispensing same
EP0862407A4 (en) * 1995-09-22 1999-03-03 Phylomed Corp TOPICAL FORMULATIONS AND ADMINISTRATION SYSTEMS

Also Published As

Publication number Publication date
AU9588598A (en) 1999-04-27
EP1019024B1 (en) 2004-01-07
WO1999017739A1 (en) 1999-04-15
ATE257372T1 (de) 2004-01-15
DE69821010T2 (de) 2004-10-28
CA2306484A1 (en) 1999-04-15
DE69821010D1 (de) 2004-02-12
EP1019024A1 (en) 2000-07-19
WO1999017739B1 (en) 1999-05-27

Similar Documents

Publication Publication Date Title
CA2219115A1 (en) N-benzyl-3-indoleacetic acids as cyclooxygenase-2-inhibitors and antiinflammatory drugs
BR9914617A (pt) Composições de unguento em aerossol e método de fabricação
WO2003004000A3 (en) Topical composition for treating pain
EP1419803A3 (en) Pharmaceutical composition for topical administration comprising an antiviral substance and a glucocorticoid
AU2745700A (en) A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
WO2002102394A3 (en) Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport
WO2002096435A3 (en) Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol
ES2170256T3 (es) Composiciones para el suministro topico de ingredientes activos.
WO2000027381A3 (en) Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions
CA2426703A1 (en) Therapeutic agents and methods of use thereof for the modulation of angiogenesis
WO2003018619A3 (en) Antimicrobial and anti-inflammatory peptides
CA2198706A1 (en) Methods for the treatment of inflammatory joint disease
WO2002009639A3 (en) Methods and pharmaceutical compositions for healing wounds
AU2732597A (en) Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
EP1157698A3 (en) Treatment of inflammatory diseases with oxypurine nucleosides
WO2001051044A3 (en) Substances for use in treating psoriasis
AU2002227052A1 (en) Treatments for neurogenetic disorders, impulse control disorders, and wound healing
AU8020698A (en) Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain
BR9815384A (pt) Composições de unguento em aerossol e método de fabricação
EP2138175A3 (en) Formulations comprising valsartan for treating diabetes or microalbuminuria
WO2003057172A3 (en) Topical application of alpha-dfmo and anti-inflammatory drug for treatment of actinic keratoses
ES2188908T3 (es) Derivados de cis-3,4-cromano utiles para la prevencion o tratamiento de sindromes relacionados con el estrogenos.
CA2404210A1 (en) Pharmaceutical gel composition
NO308586B1 (no) Anvendelse av et hormonelt middel ved fremstilling av et preparat for terapi av akne
ZA979645B (en) Heterocyclic compounds, compositions and uses.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1942 DE 25 - 03 -2008.